To investigate if the PI-RADS score represents an effective tool in detecting prostate cancer in patients treated with a 5α-reductase inhibitor (dutasteride) and to identify dedicated total serum PSA ...

PET/MRI can improve diagnostic accuracy for prostate cancer patients and help avoid unnecessary biopsies, according to new research published in the Journal of Nuclear Medicine. By applying the ...

Multiparametric magnetic resonance imaging (mpMRI) for the detection of prostate cancer (PCa) has become fundamental to better select patients with clinically significant prostate cancer (csPCa) and ...

According to a study published in the American Journal of Roentgenology (AJR), upgrade and downgrade rates from targeted biopsy to radical prostatectomy were not significantly different between ...

Shifting patterns of care in localized prostate cancer: Impact on patient reported outcome measures (PROMs). This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This abstract does ...

Disparities in receipt of molecular imaging in biochemical recurrent prostate cancer. This is an ASCO Meeting Abstract from the 2020 Genitourinary Cancers Symposium. This abstract does not include a ...

PI-RADS version 2.1 demonstrated improved detection of clinically significant prostate cancer in the transition zone. For detecting clinically significant prostate cancer (csPCa), prostate imaging ...

Innovative technology performs automatic segmentation and lesion detection in prostate MRI scans to assist in PI-RADS scoring for prostate cancer management TEL AVIV, Israel & SAN JOSE, ...

68 Ga-PSMA PET/MRI examples of PRIMARY scores. T2WI = T2-weighted image; PZ = peripheral zone; CZ = central zone. Reston, VA—PET/MRI can improve diagnostic accuracy for prostate cancer patients and ...

Upgrade and downgrade rates from targeted biopsy to radical prostatectomy were not significantly different between patients whose MRI examinations were clinically interpreted using PI-RADS Version ...